Back

Introduction.

30 August 2020 (18:30 - 18:35)
Organised by:
Congress Presentation Part of: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides Drug therapy Open Access ESC Congress 2020

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
The residual risk challenge in CVD: How important are triglycerides?
Professor U. Landmesser (Berlin, DE)
Video
Presentation thumbnail
Non-LDL in CV risk management & guidelines: What are the opportunities?
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Lessons from REDUCE-IT: How will the results impact practice?
Professor D. Bhatt (New York City, US)
Video
Presentation thumbnail
Discussion.
Professor P. Libby (Boston, US)
Video

Access the full session

Session thumbnail
Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
Video

The Event

Event poster

ESC Congress 2020

30 August 2020 18:30 CET
You may be interested in
thumbnail
Congress Presentation
Real-world experiences of dyslipidaemia in patients with high or very high cardiovascular risk.
28 August 2022
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
Icosapent ethyl in clinical practice: the Spanish experience
29 August 2025
thumbnail
Congress Presentation
Introduction
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources